EC Number | Cloned (Comment) | Organism |
---|---|---|
2.7.1.60 | cloning of isozymes mGNE1 and mGNE2, DNA and amino acid sequence determination and analysis, quantitative real-time PCR expression analysis and sequence comparison | Mus musculus |
3.2.1.183 | gene Gne1, sequence comparison with the human isozyme Gne1 | Mus musculus |
3.2.1.183 | gene Gne2, sequence comparison with the human isozyme Gne2 | Mus musculus |
EC Number | Protein Variants | Comment | Organism |
---|---|---|---|
2.7.1.60 | D176V | oral administration of the sialic acid precursor N-acetylmannosamine rescues the muscle phenotype in the transgenic Gne p.D176V mouse and partially rescues the glomerular disease and early lethality in the knockin Gne mutant M712T mouse model | Mus musculus |
2.7.1.60 | M712T | naturally occuring mutation of isozyme mGne2. Tissues of the knock-in Gne p.M712T mouse model has similar mGne transcript expression levels among genotypes, indicating no effect of the mutation on mRNA expression, but the mutant shows increased activity in presence of N-acetylmannosamine compared to the wild-type enzyme. M712T mouse mutants die within 72 h of birth from severe glomerular disease | Mus musculus |
3.2.1.183 | additional information | tissues of the knock-in Gne p.M712T mouse model have similar mGne transcript expression levels among genotypes, indicating no effect of the mutation on mRNA expression | Mus musculus |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
2.7.1.60 | Mus musculus | Q91WG8 | two mouse Gne mRNA transcripts, encoding mGne1 and mGne2, gene Gne | - |
3.2.1.183 | Mus musculus | Q3UW64 | isozyme mGne2 | - |
3.2.1.183 | Mus musculus | Q91WG8 | isozyme mGne1 | - |
3.2.1.183 | Mus musculus C57/BL6J | Q3UW64 | isozyme mGne2 | - |
3.2.1.183 | Mus musculus C57/BL6J | Q91WG8 | isozyme mGne1 | - |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
3.2.1.183 | additional information | mGne1 is the ubiquitously expressed, major mouse isoform, isozyme mGne2 encoding transcript is differentially expressed, quantitative real-time PCR isozyme expression analysis | Mus musculus | - |
3.2.1.183 | additional information | mGne2 encoding transcript is differentially expressed mGne2. Expression is significantly increased the first 2 days of life, possibly reflecting the high sialic acid demand during this period, quantitative real-time PCR isozyme expression analysis | Mus musculus | - |
EC Number | Subunits | Comment | Organism |
---|---|---|---|
2.7.1.60 | More | the GNE enzyme consists of two enzymatic domains, sequence comparisons, secondary structures, and modeling of isozymes mGNE1 and mGNE2 | Mus musculus |
3.2.1.183 | More | isozyme Gne2, secondary structure comparison with the human isozyme Gne2, the isozymes differ most in the N-terminal extension of 31 amino acids | Mus musculus |
3.2.1.183 | More | isozyme mGne1, secondary structure comparison with the human isozyme hGne1. The four homologous amino acid changes between mGne1 and hGNE1 are all located in the ManNAc kinase activity encoding domain of Gne; N447S and L523M in an alpha-helix domain, and R481Q and I484V in a coil domain, overview | Mus musculus |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
2.7.1.60 | GNE | - |
Mus musculus |
2.7.1.60 | UDP-GlcNAc 2-epimerase/ManNAc kinase | - |
Mus musculus |
3.2.1.183 | GNE | - |
Mus musculus |
3.2.1.183 | UDP-GlcNAc 2-epimerase/ManNAc kinase | - |
Mus musculus |
EC Number | Organism | Comment | Expression |
---|---|---|---|
3.2.1.183 | Mus musculus | treatment of knock-in Gne p.M712T mouse model with N-acetylmannosamine, the Gne transcript expression, in particular mGne2, increases significantly, likely resulting in increased Gne enzymatic activities, especially in kidney and skeletal muscle | up |
3.2.1.183 | Mus musculus | treatment of knock-in Gne p.M712T mouse model with N-acetylmannosamine, the Gne transcript expression, in particular mGne2, increases significantly, likely resulting in increased Gne enzymatic activities, especiallyin kidney and skeletal muscle | up |
EC Number | General Information | Comment | Organism |
---|---|---|---|
2.7.1.60 | evolution | sequence comparion and modeling of human hGNE1 and mouse mGne1 isozymmess, overview | Mus musculus |
2.7.1.60 | malfunction | non-allosteric GNE gene mutations cause the muscular disorder GNE myopathy, i.e. hereditary inclusion body myopathy. Complete Gne knockout is embryonically lethal. Transgenic mice expressing the human GNE cDNA with the D176V mutation, common among Japanese patients, in a mouse background with a disrupted mouse Gne gene recapitulates the adult onset features of human GNE myopathy with hyposialylation in serum and different organs. M712T mouse mutants die within 72 h of birth from severe glomerular disease. Mouse isozyme mutant phenotypes, overview | Mus musculus |
2.7.1.60 | metabolism | the bifunctional enzyme UDP-GlcNAc 2-epimerase/ManNAc kinase, GNE, catalyzes the first two committed steps in sialic acid synthesis | Mus musculus |
2.7.1.60 | physiological function | the mGne2 encoding transcript is differentially expressed and may act as a tissue-specific regulator of sialylation. mGne2 expression appears significantly increased the first 2 days of life, possibly reflecting the high sialic acid demand during this period | Mus musculus |
3.2.1.183 | malfunction | GNE myopathy is autosomal recessive inherited and characterized by adult onset, slowly progressive muscle weakness and atrophy | Mus musculus |
3.2.1.183 | physiological function | mGne2 encoding transcript may act as a tissue-specific regulator of sialylation | Mus musculus |